Elanco Secures FDA EUA for CLiK Extra Wound Spray to Combat New World Screwworm
Event summary
- Elanco's CLiK Extra (dicyclanil topical suspension) received FDA Emergency Use Authorization on August 7, 2026 for preventing New World screwworm infestations in livestock and wildlife.
- The spray is designed for application on or around wounds but cannot treat active infestations.
- Elanco also offers Negasunt Powder and Tanidil, which received emergency authorizations earlier in 2026, and EPA-registered Catron IV for screwworm treatment.
The big picture
The reentry of New World screwworm into the U.S. poses a significant threat to livestock and wildlife, necessitating preventive measures like CLiK Extra. Elanco's strategic response includes a suite of FDA-approved and EPA-registered products, positioning it as a key player in managing this agricultural health crisis.
What we're watching
- Regulatory Dynamics
- How the FDA's EUA framework will influence Elanco's product strategy and regulatory compliance in emergency situations.
- Market Adoption
- The pace at which livestock producers and veterinarians integrate CLiK Extra into their preventive care protocols.
- Competitive Positioning
- Whether Elanco can sustain its leadership in screwworm prevention with its portfolio of EUA products.
